The hemolytic activity of the compounds was assayed as described previously [1, 2] . Briefly, peripheral blood from healthy volunteers was collected in vacuum tubes containing heparin (Li-heparin LH, VenoSafe) as anticoagulant. Tubes were centrifuged (1000 g, 5 min) and the pellet was washed three times with RPMI-1640 (culturing medium without phenol red). RPMI medium was added to the pellet to yield a final 2% (v/v) RBC suspension. DMSO stock solutions of the compounds were diluted with medium and three-fold serial dilution series were prepared (final concentration: 0.05-100 μM, DMSO concentration: 0.5%). RBC suspension (100 L/well) were placed into a 96-well U-bottom cell culture plate and mixed with 100 L peptide solution. The plates were incubated for 2 h at 37 °C. After centrifugation (1000 g, 5 min), 100 L of the supernatant was transferred to a flat-bottom microtiter plate and absorbance was measured at 414 nm using an ELISA plate reader (iEMS Reader, Labsystems). The percentage hemolysis was compared to a hemolytic control peptide [2] (CM15, 200 μM) treated RBC and the concentration of peptide at which 50% hemolysis occurred (HC50 value) was determined. Compounds were measured in triplicates.
Cytotoxicity assay
The cytotoxic effect of the compounds was measured on murine BMDMs. Prior to treatment, cells were cultured for 24 h in serum-free RPMI medium (100,000 cells, 100 µ L/well, flat-bottom 96-well culture plate). DMSO stock solutions of the compounds were diluted with medium, and two-fold serial dilution series were prepared (final concentration: 1.5-100 μM, DMSO concentration: 0.5%). Cells were treated with the compounds for 3 h, then cell viability was tested using MTT assay [3] [4] [5] . Briefly, 45 μL MTT solution was added to each well (2 mg/mL, solved in serum-free medium). Following a 5 h incubation, plates were centrifuged at 2000 rpm for 5 minutes, and the supernatant was carefully aspirated with a G30 needle. The precipitated purple crystals were dissolved in 100 μL DMSO, and after 10 minutes agitation, the absorbance was determined at λ = 540 nm and 620 nm using an ELISA plate reader (iEMS Reader, Labsystems). Cytotoxicity, expressed in percentage as the function of compound concentration, was graphically presented, and IC50 values were determined. Data are mean ± sd of four parallel measurements. Figure S2 . Splenocyte proliferation assayed by CFSE staining method. Mice were immunized three times with either P/A/I mix (a,b,c) or with pal-A(P)I conjugate (d,e,f), at an interval of 2 weeks. Six weeks after the last immunization, single cell suspensions were prepared from the spleens and cells were re-stimulated with the antigens (c,f) for 5 days. As negative control, medium was used (a,d); as positive control, concanavalin A (ConA) was applied (b,e). On the flow cytometry histograms, proliferated cells (P2 population) were gated and the percentage compared to all cells was calculated. 
